Replimune (REPL) Cash from Financing Activities (2018 - 2025)

Replimune has disclosed Cash from Financing Activities across 8 years of filings, most recently posting $10.5 million for Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at $10.5 million, down 93.3% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.5 million (down 95.85% YoY), and the FY2025 annual result was $252.4 million, up 1450.06% from the prior year.
• Cash from Financing Activities came in at $10.5 million for Q4 2025 at Replimune, up from $324000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $271.4 million in Q4 2022 to a low of -$158000.0 in Q2 2025.
• The 5-year median for Cash from Financing Activities is $1.1 million (2021), against an average of $29.9 million.
• Across the five-year window, Cash from Financing Activities plunged 121.45% in 2023 and soared 8645.43% in 2024, its largest moves.
• Replimune's Cash from Financing Activities stood at $4.0 million in 2021, then jumped by 6738.88% to $271.4 million in 2022, then sank by 94.52% to $14.9 million in 2023, then jumped by 948.62% to $155.9 million in 2024, then tumbled by 93.3% to $10.5 million in 2025.
• The last three Cash from Financing Activities figures came in at $10.5 million (Q4 2025), $324000.0 (Q3 2025), and -$158000.0 (Q2 2025), per Business Quant data.